Somatic symptom disorder
Somatic Symptom Disorder (DSM-5-TR 300.82) is characterized by one or more distressing somatic symptoms accompanied by excessive thoughts, feelings, or behaviors related to the symptoms or associated health concerns, persisting for at least six months.
Overview
Somatic Symptom Disorder (SSD; DSM-5-TR 300.82) is a Somatic Symptom and Related Disorders class diagnosis characterized by one or more distressing somatic (physical) symptoms accompanied by excessive thoughts, feelings, or behaviors related to those symptoms or associated health concerns. The disorder represents a substantial revision of the DSM-IV “somatoform disorders” framework: SSD does not require that symptoms be medically unexplained; it can co-occur with documented medical illness, focusing instead on the disproportionate psychological response.
SSD prevalence in general populations is estimated at approximately 5-7%, with substantially higher rates in primary care and consultation-liaison settings. The disorder is more common in women than men. Onset is typically in early adulthood, often following a period of medical illness or significant psychosocial stress.
The DSM-5-TR Somatic Symptom and Related Disorders chapter includes SSD plus Illness Anxiety Disorder (300.7, formerly hypochondriasis with high health anxiety but few somatic symptoms), Conversion Disorder (Functional Neurological Symptom Disorder, 300.11), Psychological Factors Affecting Other Medical Conditions (316), and Factitious Disorder (300.19). The chapter consolidates and modernizes the previous somatoform disorders framework with greater attention to the patient’s cognitive and emotional response rather than focusing on symptom origin.
SSD is highly comorbid with depression, anxiety disorders, panic disorder, and personality disorders. Approximately 30-60% of patients have at least one comorbid mental-health condition; physical-health comorbidities are also common, often representing the substrate for the somatic preoccupation.
Treatment is effective for most who engage. Cognitive behavioural Therapy for SSD has the strongest evidence base; Mindfulness-Based Cognitive Therapy and Acceptance and Commitment Therapy are also useful. Pharmacotherapy with SSRIs is appropriate for comorbid depression and anxiety. Effective treatment substantially reduces symptom-related distress, healthcare utilization, and functional impairment.
Signs and symptoms
- Distressing somatic symptoms — One or more physical symptoms — pain, fatigue, gastrointestinal symptoms, neurological symptoms, others — that are distressing or significantly disrupt daily life.
- Disproportionate thoughts about symptoms — Persistent thoughts about the seriousness of symptoms; catastrophic interpretations; preoccupation with what the symptoms might mean.
- High anxiety about health or symptoms — Persistent worry, anxiety, or fear about symptoms or their possible underlying causes.
- Excessive time and energy on symptoms — Substantial time and energy devoted to symptoms or health concerns — researching, monitoring, seeking medical evaluation, accommodating symptoms.
- Repeated medical evaluation seeking — Multiple consultations across providers; "doctor shopping"; persistent dissatisfaction with reassurance; request for additional testing despite negative results.
- Avoidance of activities — Reduction in work, social, or recreational activities due to symptoms or fear of worsening symptoms.
- Functional impairment — Significant impact on work, relationships, daily activities, and quality of life.
- Co-occurring depression and anxiety — Frequent comorbid mood and anxiety symptoms, often arising from or exacerbating somatic preoccupation.
- Healthcare-relationship difficulties — Frustration with healthcare providers; sense of being dismissed; conflict over diagnosis or treatment plans.
- Persistent course — Symptoms persist for 6 months or more, often years; chronic course is typical.
Diagnostic context
The DSM-5-TR criteria for Somatic Symptom Disorder (300.82):
- A. One or more somatic symptoms that are distressing or result in significant disruption of daily life.
- B. Excessive thoughts, feelings, or behaviors related to the somatic symptoms or associated health concerns as manifested by at least one of: (1) disproportionate and persistent thoughts about the seriousness of one’s symptoms; (2) persistently high level of anxiety about health or symptoms; (3) excessive time and energy devoted to these symptoms or health concerns.
- C. Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically more than 6 months).
Specifiers: with predominant pain (formerly “Pain Disorder”); persistent (severe symptoms, marked impairment, long duration ≥6 months); severity (mild, moderate, severe based on number of B-criteria symptoms).
The DSM-5-TR removed the requirement (present in DSM-IV) that somatic symptoms be medically unexplained. SSD can be diagnosed in patients with diagnosed medical conditions when their psychological response to symptoms is disproportionate.
Differential diagnosis includes:
- Illness Anxiety Disorder (300.7) — preoccupation with serious illness without significant somatic symptoms.
- Conversion Disorder (300.11) — neurological symptoms (motor, sensory, seizure, mixed) inconsistent with neurological disease.
- Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder — somatic symptoms may be features of these primary conditions.
- Factitious Disorder — intentional symptom production for psychological gain (sick role).
- Malingering — intentional symptom production for external gain (financial, legal); not a mental disorder.
- Underlying medical conditions — must be carefully evaluated; SSD diagnosis does not preclude medical disease.
Validated assessment instruments include the Somatic Symptom Scale-8 (SSS-8), Patient Health Questionnaire-15 (PHQ-15), and Health Anxiety Inventory.
Causes and risk factors
SSD develops through interaction of biological, psychological, and social factors:
Genetic factors: moderate heritability; family aggregation with mood, anxiety, and other somatic symptom disorders.
Neurobiological factors: altered interoceptive awareness (perception of internal bodily states), increased attention to bodily sensations, abnormalities in brain regions processing pain and bodily signals (insula, anterior cingulate cortex), HPA axis dysfunction.
Developmental factors: childhood adversity (particularly chronic illness, sexual abuse, parental illness or death), early modelling of illness behaviour in family, and early experiences with medical care all elevate risk.
Psychological factors: alexithymia (difficulty identifying and describing emotions), high health anxiety, catastrophic thinking about bodily sensations, attention focus on body, and certain personality features all elevate risk.
Comorbid medical conditions: chronic illness, recent medical procedure, or recent medical scare often precipitate or exacerbate SSD.
Comorbid mental-health conditions: depression, anxiety disorders, panic disorder, PTSD, and personality disorders are commonly comorbid; symptoms often interact bidirectionally.
Social and contextual factors: family illness culture, healthcare-system experiences, cultural meanings of illness, and gender (women more frequently diagnosed) all influence presentation.
Healthcare-system factors: repeated negative diagnostic workups, dismissive provider interactions, and fragmented care can exacerbate the disorder.
Typical treatments
Effective treatment combines psychological, pharmacological, and care-coordination approaches:
Cognitive behavioural Therapy: strongest evidence base. CBT for SSD addresses cognitive distortions (catastrophic interpretations, all-or-nothing thinking about symptoms), behavioural patterns (avoidance, excessive checking, repeated medical evaluation), and emotional processing. 12-20 session structured protocols are typical.
Mindfulness-Based Cognitive Therapy (MBCT): develops capacity to observe bodily sensations without catastrophic interpretation; growing evidence for somatic symptom disorders.
Acceptance and Commitment Therapy (ACT): values clarification, defusion from symptom-related thoughts, committed action despite symptoms. Particularly resonant for chronic-symptom presentations.
Brief Reattribution Therapy: structured short-term approach (Goldberg) for primary-care SSD, focusing on broadening the patient’s explanatory model from purely physical to biopsychosocial.
Body-oriented approaches: Sensorimotor Psychotherapy, Somatic Experiencing, mindful movement (yoga, tai chi) — useful when trauma history is present.
Pharmacotherapy: SSRIs and SNRIs are appropriate for comorbid depression, anxiety, and panic. Tricyclic antidepressants (low-dose amitriptyline, nortriptyline) have evidence for chronic pain presentations. Pharmacotherapy is typically adjunctive rather than primary.
Care coordination: a stable, trusted primary care relationship reduces “doctor shopping,” excessive testing, and conflicting care plans. Many SSD patients benefit from a single coordinating physician with regular scheduled appointments rather than as-needed visits.
Physical activity and graded exercise: gradual increase in physical activity is appropriate for many somatic presentations and supports both physical and psychological recovery.
Treatment of comorbid medical conditions: when chronic medical conditions are part of the substrate, optimal medical management reduces symptom load and supports psychological recovery.
Family education and involvement: family members often feel helpless or frustrated; education about SSD and structured involvement support recovery.
When to seek help
Professional evaluation is indicated when:
- You have one or more persistent physical symptoms that are causing significant distress or impairment.
- You are spending substantial time worrying about symptoms or their possible underlying causes.
- You have had multiple medical evaluations without finding adequate explanation, or with explanations that do not satisfy you.
- You have reduced work, social, or recreational activities due to symptoms or fear of symptoms.
- You are experiencing depression, anxiety, or other mental-health symptoms alongside the physical symptoms.
- Healthcare interactions have become increasingly frustrating or conflicted.
- Family members or trusted others have expressed concern about your preoccupation with symptoms.
For mental-health crisis: 9-8-8 (Suicide Crisis Helpline), 1-833-456-4566 (Talk Suicide Canada), 811 (Health Link, non-emergency).
Frequently asked questions
Are my symptoms "all in my head"?
How is SSD different from hypochondria?
How is conversion disorder different from SSD?
Will medication help?
Will I have to stop seeking medical care?
How long does treatment take?
References
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
- Henningsen, P., et al. (2018). Management of functional somatic syndromes and bodily distress. Psychotherapy and Psychosomatics, 87(1), 12–31.
- Allen, L. A., et al. (2006). Cognitive-behavioural therapy for somatization disorder: A randomized controlled trial. Archives of Internal Medicine, 166(14), 1512–1518.
- Kroenke, K. (2007). Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosomatic Medicine, 69(9), 881–888.
- Dimsdale, J. E., et al. (2013). Somatic symptom disorder: An important change in DSM. Journal of Psychosomatic Research, 75(3), 223–228.
Find the pattern behind what's been feeling hard
A few simple questions to help surface the concerns that may fit best.
Find Your PatternFind a Therapist by City
Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.
Find a Therapist by Province
Browse therapy options by province to see which clinicians are available to work with clients in your region.
Trusted by Leading Psychology & Mental Health Organizations Across Canada
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Trusted By Alberta’s Leading Psychology & Mental Health Organizations
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.
Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.
